Catherine Mezzacappa

Catherine Mezzacappa is an Instructor in the Division of Digestive Diseases at the Yale School of Medicine. Her research focuses on integrating genetic and lived risk factors for hepatocellular carcinoma to enhance medical decision-making for liver cancer screening and treatment. She holds an MD from the University of Pennsylvania (2018) and an MPH in Epidemiology from Boston University (2011), where she received the Dr. Theodore Colton Prize for Excellence in Epidemiology.

• Current roles: Instructor, Division of Digestive Diseases, Yale School of Medicine
• Research themes: Liver cancer, metabolic liver disease, medication safety, telemedicine

Her work spans collaborations with the Yale Liver Center and frequent co-authors including Tamar Taddei and Amy Justice. Recent publications highlight applications of natural language processing for liver disease identification, hepatotoxicity scoring models, and revised REACH-B algorithms for hepatitis B-related cancer prediction. She has received multiple awards, including the Kushlan Award for Excellence in Research (2024) and the James L. Boyer Fellows Award.

Scientific Awards:

• 2024: Kushlan Award for Excellence in Research (Yale)
• 2022: Professor Margit Hamosh Memorial Travel Award (AASLD)
• 2022: James L. Boyer Fellows Research Award (Yale)

Her research intersects clinical medicine, epidemiology, and health informatics, with recent work emphasizing real-world data and population health approaches. She actively contributes to AASLD committees and serves as an AGA Editorial Fellow.